70248 Federal Register / Vol. 75, No. 221 / Wednesday, November 17, 2010 / Notices 

restrictions on the use of lead tackle in 

the state. Other states have outreach and 

education and tackle exchange 

programs. 

The comments that EPA has received 

from states and a state organization 

highlight the geographic focus of state 

controls on lead fishing tackle. 

According to the Association of Fish 

and Wildlife Agencies, ‘‘the exposure to 

certain migratory birds (primarily loons, 

and to a lesser extent, swans) and 

related impacts to populations of those 

birds is localized, and where impacts 

have been substantiated to be 

significant, state fish and wildlife 

agencies have acted to regulate the use 

of lead sinkers and jigs. In the northeast, 

five states have enacted restrictions 

(e.g., ban in certain bodies of water; ban 

on certain weights and sizes) on the use 

of lead fishing tackle where studies have 

identified lead toxicosis as a 

contributing factor to declining loon 

populations. Some states are also 

offering a fishing tackle exchange 

program (non-lead for lead products). 

States have thus demonstrated a 

responsible exercise of their authority to 

regulate or restrict lead fishing tackle 

under circumstances of exposure where 

it contributes to decline in loon 

populations’’ (Ref. 2). 

Several state fish and game agencies 

submitted comments (Refs. 3–5). All 

support denial of the petition and 

provide several reasons why they do not 

support the actions requested in the 

petition. These comments assert that 

mortality from ingestion of lead fishing 

tackle is rare and is primarily limited to 

some areas of the country, that states are 

already working closely with the Fish 

and Wildlife Service on education and 

exchange programs, and that where 

there have been impacts on loons and 

trumpeter swans, states have already 

taken action. These states contend that 

these impacts are best addressed by 

geographically targeted actions that the 

states are undertaking. As noted by 

these commenters, states in the northern 

part of the country, where the majority 

of the impacts on loons has been 

observed, have taken action to limit or 

ban the use of lead sinkers or have 

implemented tackle exchange programs. 

While it is the case, as petitioners 

noted, that 16 years ago, in 1994, EPA 

proposed a ban of lead for use in certain 

smaller-sized fishing sinkers under 

TSCA section 6(a)(2)(A), the sweeping 

alternative requested by petitioners was 

not one the Agency, as reflected in its 

proposal, found to be appropriate even 

then. (59 FR 11122, March 9, 1994). The 

steps that have been taken at the Federal 

and State levels since that time make a 

nationwide ban on all lead fishing gear 

such as that sought by petitioners even 

less appropriate today. 

Moreover, the market for fishing gear 

is changing. While lead tackle may still 

constitute the largest percentage of the 

fishing sinker market, over the last 

decade the availability of fishing sinkers 

made from other materials has 

expanded. New non-lead products have 

entered the market, and the market 

share of lead sinkers has decreased. 

With improvements in technology, 

changes in consumer preferences, statelevel restrictions, and increased market 

competition, the market for lead fishing 

sinkers is expected to continue to 

decrease while the market for 

substitutes such as limestone, steel, and 

tungsten fishing sinkers is expected to 

continue to increase (Ref. 6). 

In sum, EPA is not persuaded that the 

action requested by the petitioners—a 

sweeping national uniform rule on lead 

in all fishing gear—is necessary. The 

petitioners also have failed to 

demonstrate that a national ban on lead 

fishing gear is the least burdensome 

approach to adequately address the risk 

to the environment addressed in the 

petition, as required by TSCA section 6, 

given the mix of actions that state 

agencies and the Federal Government 

already are taking to address the impact 

of lead fishing sinkers on local 

environments. The risk described by the 

petitioners does appear to be more 

prevalent in some geographic areas than 

others, and the trend over the past 

decade has been for increasing state and 

localized activity regarding lead in 

fishing gear. For these reasons, EPA 

denied the petitioners’ request for a 

national ban on lead in all fishing gear. 

V. References 

1. American Bird Conservancy, Petition to 

the Environmental Protection Agency to Ban 

Lead Shot, Bullets and Fishing Sinkers under 

the Toxic Substances Control Act. August 3, 

2010. 

2. Association of Fish and Wildlife 

Agencies. Letter to Honorable Lisa Jackson, 

Administrator, United States Environmental 

Protection Agency. September 2, 2010. 

3. The State of Arizona Game and Fish 

Department. Letter to Lisa P. Jackson, 

Administrator, United States Environmental 

Protection Agency. September 14, 2010. 

4. Kentucky Department of Fish & Wildlife 

Resources Tourism, Art and Heritage Cabinet. 

Letter to Honorable Lisa Jackson, 

Administrator, United States Environmental 

Protection Agency. September 15, 2010. 

5. Commonwealth of Virginia Department 

of Game and Inland Fisheries. Letter to 

Honorable Lisa Jackson, Administrator, 

United States Environmental Protection 

Agency. September 15, 2010. 

6. Background Document—TSCA § 21 

Petition; Pb in Fishing Sinkers and Other 

Components. October 2010. 

List of Subjects 

Environmental protection, Bird, Lead, 

Lead bullets, Lead fishing sinkers, Lead 

shot. 

Dated: November 4, 2010. 

Steve A. Owens, 

Assistant Administrator, Office of Chemical 

Safety and Pollution Prevention. 

[FR Doc. 2010–28972 Filed 11–16–10; 8:45 am] 

BILLING CODE 6560–50–P 

ENVIRONMENTAL PROTECTION 

AGENCY 

[EPA–HQ–OPPT–2009–0477; FRL–8848–7] 

Endocrine Disruptor Screening 

Program; Second List of Chemicals for 

Tier 1 Screening 

AGENCY: Environmental Protection 

Agency (EPA). 

ACTION: Notice. 

SUMMARY: This document announces the 

second list of chemicals and substances 

for which EPA intends to issue test 

orders under the Endocrine Disruptor 

Screening Program (EDSP). EPA 

established the EDSP in response to 

section 408(p) of the Federal Food, 

Drug, and Cosmetic Act (FFDCA). This 

second list of chemicals expands the 

EDSP in an effort to include all 

pesticides, required by FFDCA, and 

adds priority drinking water chemicals 

into the program for screening as 

authorized by SDWA section 1457. 

Today’s publication provides public 

notice of EPA’s tentative decisionmaking in advance of the actual 

issuance of EDSP testing orders. 

DATES: In order for the Agency to 

consider information and/or comments 

that may be relevant to the inclusion or 

exclusion of chemicals contained on the 

second EDSP list, this information and/ 

or comments should be received by EPA 

on or before December 17, 2010. 

ADDRESSES: Submit your comments, 

identified by docket identification (ID) 

number EPA–HQ–OPPT–2009–0477, by 

one of the following methods: 

• Federal eRulemaking Portal: http:// 

www.regulations.gov. Follow the on-line 

instructions for submitting comments. 

• Mail: Document Control Office 

(7407M), Office of Pollution Prevention 

and Toxics (OPPT), Environmental 

Protection Agency, 1200 Pennsylvania 

Ave., NW., Washington, DC 20460– 

0001. 

• Hand Delivery: OPPT Document 

Control Office (DCO), EPA East Bldg., 

Rm. 6428, 1201 Constitution Ave., NW., 

Washington, DC. Attention: Docket ID 

Number EPA–HQ–OPPT–2009–0477. 

The DCO is open from 8 a.m. to 4 p.m., 

mstockstill on DSKH9S0YB1PROD with NOTICES

Federal Register / Vol. 75, No. 221 / Wednesday, November 17, 2010 / Notices 70249 

Monday through Friday, excluding legal 

holidays. The telephone number for the 

DCO is (202) 564–8930. Such deliveries 

are only accepted during the DCO’s 

normal hours of operation, and special 

arrangements should be made for 

deliveries of boxed information. 

Instructions: Direct your comments to 

docket ID number EPA–HQ–OPPT– 

2009–0477. EPA’s policy is that all 

comments received will be included in 

the docket without change and may be 

made available on-line at http:// 

www.regulations.gov, including any 

personal information provided, unless 

the comment includes information 

claimed to be Confidential Business 

Information (CBI) or other information 

whose disclosure is restricted by statute. 

Do not submit information that you 

consider to be CBI or otherwise 

protected through regulations.gov or 

e-mail. The regulations.gov Web site is 

an ‘‘anonymous access’’ system, which 

means EPA will not know your identity 

or contact information unless you 

provide it in the body of your comment. 

If you send an e-mail comment directly 

to EPA without going through 

regulations.gov, your e-mail address 

will be automatically captured and 

included as part of the comment that is 

placed in the docket and made available 

on the Internet. If you submit an 

electronic comment, EPA recommends 

that you include your name and other 

contact information in the body of your 

comment and with any disk or CD–ROM 

you submit. If EPA cannot read your 

comment due to technical difficulties 

and cannot contact you for clarification, 

EPA may not be able to consider your 

comment. Electronic files should avoid 

the use of special characters, any form 

of encryption, and be free of any defects 

or viruses. 

Docket: All documents in the docket 

are listed in the docket index available 

at http://www.regulations.gov. Although 

listed in the index, some information is 

not publicly available, e.g., CBI or other 

information whose disclosure is 

restricted by statute. Certain other 

material, such as copyrighted material, 

is not placed on the Internet and will be 

publicly available only in hard copy 

form. Publicly available docket 

materials are available either in the 

electronic docket at http:// 

www.regulations.gov, or, if only 

available in hard copy, at the OPPT 

Docket. The OPPT Docket is located in 

the EPA Docket Center (EPA/DC) at Rm. 

3334, EPA West Bldg., 1301 

Constitution Ave., NW., Washington, 

DC. The EPA/DC Public Reading Room 

hours of operation are 8:30 a.m. to 

4:30 p.m., Monday through Friday, 

excluding legal holidays. The telephone 

number of the EPA/DC Public Reading 

Room is (202) 566–1744, and the 

telephone number for the OPPT Docket 

is (202) 566–0280. Docket visitors are 

required to show photographic 

identification, pass through a metal 

detector, and sign the EPA visitor log. 

All visitor bags are processed through 

an X-ray machine and subject to search. 

Visitors will be provided an EPA/DC 

badge that must be visible at all times 

in the building and returned upon 

departure. 

FOR FURTHER INFORMATION CONTACT: For 

technical information contact: William 

Wooge, Office of Science Coordination 

and Policy, Environmental Protection 

Agency, 1200 Pennsylvania Ave., NW., 

Washington, DC 20460–0001; telephone 

number: (202) 564–8476; e-mail address: 

wooge.william@epa.gov. 

For general information contact: The 

TSCA-Hotline, ABVI-Goodwill, 422 

South Clinton Ave., Rochester, NY 

14620; telephone number: (202) 554– 

1404; e-mail address: TSCAHotline@epa.gov. 

SUPPLEMENTARY INFORMATION: 

I. General Information 

A. Does this action apply to me? 

You may be potentially affected by 

this action if you produce, manufacture, 

use, consume, work with, or import 

substances included on the second 

EDSP list. Potentially affected entities 

may include, but are not limited to: 

• Chemical manufacturers, importers 

and processors (NAICS code 325), e.g., 

persons who manufacture, import or 

process chemical substances. 

• Pesticide, fertilizer, and other 

agricultural chemical manufacturers 

(NAICS code 3253), e.g., persons who 

manufacture, import or process 

pesticide, fertilizer and agricultural 

chemicals. 

• Scientific research and 

development services (NAICS code 

5417), e.g., persons who conduct testing 

of chemical substances for endocrine 

effects. 

This listing is not intended to be 

exhaustive, but rather provides a guide 

for readers regarding entities likely to be 

affected by this action. Other types of 

entities not listed in this unit could also 

be affected. The North American 

Industrial Classification System 

(NAICS) codes have been provided to 

assist you and others in determining 

whether this action might apply to 

certain entities. If you have any 

questions regarding the applicability of 

this action to a particular entity, consult 

the technical person listed under FOR

FURTHER INFORMATION CONTACT. 

B. What should I consider as I prepare 

my comments for EPA? 

1. Submitting CBI. Do not submit this 

information to EPA through 

regulations.gov or e-mail. Clearly mark 

the part or all of the information that 

you claim to be CBI. For CBI 

information in a disk or CD–ROM that 

you mail to EPA, mark the outside of the 

disk or CD–ROM as CBI and then 

identify electronically within the disk or 

CD–ROM the specific information that 

is claimed as CBI. In addition to one 

complete version of the comment that 

includes information claimed as CBI, a 

copy of the comment that does not 

contain the information claimed as CBI 

must be submitted for inclusion in the 

public docket. Information so marked 

will not be disclosed except in 

accordance with procedures set forth in 

40 CFR part 2. 

2. Tips for preparing your comments. 

When submitting comments, remember 

to: 

i. Identify the document by docket ID 

number and other identifying 

information (subject heading, Federal 

Register date and page number). 

ii. Follow directions. The Agency may 

ask you to respond to specific questions 

or organize comments by referencing a 

Code of Federal Regulations (CFR) part 

or section number. 

iii. Explain why you agree or disagree; 

suggest alternatives and substitute 

language for your requested changes. 

iv. Describe any assumptions and 

provide any technical information and/ 

or data that you used. 

v. If you estimate potential costs or 

burdens, explain how you arrived at 

your estimate in sufficient detail to 

allow for it to be reproduced. 

vi. Provide specific examples to 

illustrate your concerns and suggest 

alternatives. 

vii. Explain your views as clearly as 

possible, avoiding the use of profanity 

or personal threats. 

viii. Make sure to submit your 

comments by the comment period 

deadline identified. 

II. Introduction 

A. What action is the agency taking? 

Today’s document announces the 

second list of chemicals that the Agency 

intends to include in its EDSP. Through 

the issuance of orders, the Agency 

intends to require the submission of 

Tier 1 Screening data for these 

chemicals. Elsewhere in today’s issue of 

the Federal Register, EPA also is 

announcing the policies and procedures 

expected to be followed for certain 

chemicals on this list. Information on 

EDSP and Tier 1 Screening data is 

mstockstill on DSKH9S0YB1PROD with NOTICES

70250 Federal Register / Vol. 75, No. 221 / Wednesday, November 17, 2010 / Notices 

available on the Agency’s Web site at 

http://www.epa.gov/endo. 

B. What is the agency’s authority for 

taking this action? 

EPA’s authority for taking this action 

is based on several different 

Congressional actions, including 

FFDCA, the Safe Drinking Water Act 

(SDWA), and the House Appropriations 

Committee report for EPA’s FY 2010 

appropriations. 

EPA developed the EDSP in 1998 to 

implement FFDCA section 408(p), 

which requires EPA to ‘‘develop a 

screening program, using appropriate 

validated test systems and other 

scientifically relevant information, to 

determine whether certain substances 

may have an effect in humans that is 

similar to an effect produced by a 

naturally occurring estrogen, or such 

other endocrine effect as [EPA] may 

designate.’’ (21 U.S.C. 346a(p)). The 

statute generally requires EPA to 

‘‘provide for the testing of all pesticide 

chemicals’’ and gives EPA discretionary 

authority to ‘‘provide for the testing of 

any other substance that may have an 

effect that is cumulative to an effect of 

a pesticide chemical if the 

Administrator determines that a 

substantial population may be exposed 

to such a substance.’’ (21 U.S.C. 

346a(p)(3)). The statute also authorizes 

EPA to exempt a chemical upon a 

determination that ‘‘the substance is 

anticipated not to produce any effect in 

humans similar to an effect produced by 

a naturally occurring estrogen.’’ (21 

U.S.C. 346a(p)(4)). 

Section 1457 of SDWA provides that 

‘‘in addition to the substances’’ referred 

to in FFDCA section 408(p)(3)(B), ‘‘the 

Administrator may provide for testing 

under the screening program authorized 

by section 408(p) of such Act, in 

accordance with the provisions of 

section 408(p) of such Act, of any other 

substance that may be found in sources 

of drinking water if the Administrator 

determines that a substantial population 

may be exposed to such substance.’’ (42 

U.S.C. 300j–17). EPA used its authority 

under SDWA to identify a portion of the 

chemicals on the second EDSP list. 

In addition, in Congress’s House 

Appropriations Committee report for 

EPA’s FY 2010 appropriations (H.R. 

2996, H. Rept. 111–180) (Ref. 1), it 

directed EPA ‘‘to publish within 1 year 

of enactment a second list of no less 

than 100 chemicals for screening that 

includes drinking water contaminants, 

such as halogenated organic chemicals, 

dioxins, flame retardants (PBDEs, PCBs, 

PFCs), plastics (BPA), pharmaceuticals 

and personal care products, and issue 

25 orders per year for the testing of 

these chemicals.’’ 

III. Background 

EPA developed EDSP in response to 

a Congressional mandate in FFDCA ‘‘to 

determine whether certain substances 

may have an effect in humans that is 

similar to an effect produced by a 

naturally occurring estrogen, or such 

other endocrine effect as [EPA] may 

designate’’ (21 U.S.C. 346a(p)). As part 

of EDSP, EPA issues orders to collect 

certain test data on listed chemical 

substances. Unit II.B. describes the 

authority for listing a chemical. Test 

data requirements are derived from 

specific test assays, which are divided 

into two tiers. Tier I test assays are used 

to screen the chemicals for interaction 

with the estrogen (E), androgen (A) or 

thyroid (T) hormonal systems. Tier II 

test assays are intended to test for more 

specific chemical effects on the 

endocrine system, and are currently in 

the process of being developed and 

validated. Further information regarding 

EDSP and requirements for Tier I and 

Tier II can be found on the Agency’s 

EDSP Web site, at http://www.epa.gov/ 

endo/. 

IV. Development of the Second EDSP 

List 

In developing the second EDSP list, 

EPA focused on a subset of chemicals 

and substances that have been listed as 

priorities within EPA’s drinking water 

and pesticides programs. While the 

Agency has not included some 

chemicals or substances on the second 

EDSP list as explained in Unit IV.A., 

non-inclusion does not mean that these 

other chemicals or substances may not 

be subject to testing in the near term nor 

in the future. In addition, based on 

current information, the public should 

not presume that the listing of a 

chemical or substance indicates in any 

way that EPA currently suspects that 

such chemical or substance interferes 

with the endocrine systems of humans 

or other species simply because it has 

been listed for screening under the 

EDSP. At the present time, EPA believes 

that these chemicals or substances 

should be candidates, at least for 

screening purposes, under EDSP testing 

based only on their pesticide 

registration status and/or because such 

substances may occur in sources of 

drinking water to which a substantial 

population may be exposed. 

A. Basis for Chemical Selection 

The Agency considered chemicals 

contained on the Office of Water (OW) 

and Office of Pesticide Programs (OPP) 

priority lists for inclusion on the second 

EDSP list. 

1. Initial compilation of OW 

candidate chemicals. The Agency 

identified candidate chemicals that are 

either contaminants regulated with a 

national primary drinking water 

regulation (NPDWR) (40 CFR part 141) 

(Ref. 2) or are unregulated contaminants 

that are listed on the third Contaminant 

Candidate List (CCL 3) (USEPA, 2009) 

(Ref. 3). EPA began with the 85 

regulated drinking water contaminants 

with existing NPDWRs and the 116 

unregulated contaminants listed on CCL 

3 because these represent many of the 

priority contaminants for the drinking 

water program. Most of the regulated 

drinking water contaminants with 

NPDWRs were designated by Congress 

under the 1986 or the1996 SDWA 

amendments. Because Congress 

designated these contaminants for 

regulation due to concerns about 

occurrence in drinking water and 

adverse impacts on human health, EPA 

believes that each such substance meets 

the statutory testing criteria from SDWA 

section 1457. SDWA section 1412(b)(9) 

requires the Agency to periodically 

review the existing NPDWRs and revise 

them, if appropriate. Information about 

the potential for endocrine disruption 

will assist the Agency in updating 

human health assessments, which the 

Agency considers in its periodic review 

of NPDWRs to ensure that they are 

protective of human health. 

SDWA section 1412(b)(1) requires the 

Agency to develop a list of unregulated 

contaminants that are known or 

anticipated to occur in public water 

systems (PWSs) and may require 

regulation under SDWA. The Agency is 

required to develop the CCL list every 

5 years. In determining whether a 

substance may occur in drinking water, 

EPA considers not only public water 

system monitoring data, but also data on 

ambient concentrations in surface water 

and ground water, and releases to the 

environment (e.g., reporting data from 

the Toxics Release Inventory). The 

Agency believes that such data are 

sufficient to anticipate contaminants 

that may occur in public water systems 

and furthermore, also represent those 

substances that may be found in sources 

of drinking water and to which a 

substantial population may be exposed. 

In selecting contaminants for the CCL, 

SDWA section 1412(b)(1)(C) requires 

that the Agency ‘‘take into 

consideration, among other factors of 

public health concern, the effect of such 

contaminants upon subgroups that 

comprise a meaningful portion of the 

general population (such as infants, 

children, pregnant women, the elderly, 

mstockstill on DSKH9S0YB1PROD with NOTICES

Federal Register / Vol. 75, No. 221 / Wednesday, November 17, 2010 / Notices 70251 

individuals with a history of serious 

illness, or other subpopulations) that are 

identifiable as being at greater risk of 

adverse health effects due to exposure to 

contaminants in drinking water than the 

general population.’’ The protocol that 

EPA used to develop CCL 3 was 

reviewed by internal experts, as well as 

external experts such as the National 

Drinking Water Advisory Council and 

the Science Advisory Board (Ref. 3). The 

CCL 3 has undergone a rigorous listing 

and expert review process, including a 

public nomination and comment period, 

and therefore, represent an excellent 

source of potential drinking water 

candidates to consider for EDSP 

screening. The information about the 

potential for endocrine disruption will 

assist the Agency in evaluating the 

human health impacts of unregulated 

drinking water contaminants. In the 

CCL listing, EPA already has made the 

component of the SDWA section 1457 

determination that such substances may 

occur in sources of drinking water. The 

final CCL 3 listing also represents EPA’s 

determination that a substantial 

population may be exposed to such 

substance for the purposes of SDWA 

1457. 

In listing drinking water contaminants 

on the CCL 3, EPA closely evaluated the 

nature of the occurrence and prevalence 

information supporting each such CCL 3 

listing. Evaluating occurrence, EPA 

considered and evaluated data based on 

occurrence in finished drinking water 

and ambient water, as well as based on 

total releases to the environment, 

pesticide application rates, and 

production volumes (73 FR 9628, 

February 21, 2008) (FRL–8529–7). In 

deciding whether to move a possible 

drinking water contaminant from the 

preliminary CCL 3 to the proposed CCL 

3, EPA scored each such contaminant 

based on, among other attributes, its 

occurrence attributes (at 73 FR 9640–41, 

February 21, 2008). The occurrence 

attributes were weighted more heavily 

based on a hierarchy representing 

prevalence of the contaminant in the 

water environment or likely release to 

the water environment. The results of 

that scoring are described at 73 FR 9644, 

February 21, 2008. The administrative 

record supporting the CCL 3 ultimately 

published in 2009 includes 

contaminant-by-contaminant 

information sheets that document the 

occurrence data upon which EPA relied 

for the listing of CCL 3 contaminants. 

The basis for EPA’s inclusion of the CCL 

3 contaminants on its tentative testing 

list, therefore, also provides the basis for 

EPA’s determination that a substantial 

population may be exposed to each such 

substance for the purposes of SDWA 

section 1457. 

2. Initial compilation of OPP 

candidate chemicals. The Agency 

identified candidate chemicals from 

OPP based on pesticides that were 

scheduled for Registration Review 

during fiscal years 2007 and 2008. This 

selection is part of the Agency’s intent 

to efficiently expedite the testing of 

pesticides by conducting the testing in 

parallel or as part of the OPP 

Registration Review program. 

3. Streamlining the second EDSP list. 

Consolidating the lists of OW and OPP 

chemicals resulted in over 200 

chemicals. A listing of these chemicals 

is available in the docket for this notice 

(Ref. 4). The Agency streamlined this 

initial second EDSP list by excluding 

any chemical that fell into one or more 

of the following categories: 

i. Biological agent and naturally 

occurring chemicals (e.g., microbials, 

microbial toxins, inorganics, 

radionuclides). 

ii. Chemicals for which the 

manufacturer, importer or registrant 

cannot be clearly identified (e.g., 

disinfection byproducts or DBPs, 

microbes, microbial toxins, degradate 

compounds with more than one 

possible source). 

iii. Chemicals already included on the 

first EDSP list because these chemicals 

have already received an EDSP order. 

Note however that if no one agreed to 

provide data in response to that order, 

additional orders may be issued under 

a SDWA determination. 

iv. Chemicals that are hormones with 

confirmed endocrine effects. 

v. Chemicals not likely to be 

biologically active or which are 

incompatible with testing assays for 

various reasons due to one or more of 

their physiochemical properties (e.g., 

gases, strongly acidic or basic, 

solubility, vapor pressure molecular 

weight). 

vi. Pesticides that are scheduled for 

registration review after FY 2008. 

Although these chemicals have been 

excluded from the second EDSP list for 

one or more of these reasons, it is 

important to note that these exclusions 

do not imply that the Agency has no 

interest in the potential for endocrine 

disruption activity for these chemicals. 

In some instances, the Agency 

recognizes that information on 

endocrine effects is already available 

(e.g., for the hormones) or the Agency is 

currently collecting information (e.g., 

through the first EDSP list). In other 

cases, the Agency simply realizes that at 

this time there is some difficulty with 

collecting the information about 

endocrine effects through the EDSP (i.e., 

because of the Agency’s inability to 

identify a manufacturer, importer, or 

registrant or because the contaminant is 

incompatible with the testing assays). In 

addition, EPA recognizes that some of 

the naturally occurring chemicals also 

have anthropogenic sources and should 

be considered for the EDSP. In no way 

should it be inferred that removal from 

this initial second EDSP list signifies 

that a chemical does not have the 

potential to be placed on a future EDSP 

chemical list. The Agency intends to 

reexamine currently excluded chemicals 

for future EDSP chemical lists. 

EPA is interested in receiving 

information from the public that may 

help the Agency resolve the difficulties 

with the currently excluded chemicals 

so that the Agency will be able to 

consider adding them to future EDSP 

chemical lists. 

B. Second EDSP List of Chemicals 

There are approximately 134 

chemicals on the second ESDP list (see 

Table 1). This list includes a large 

number of pesticides, two 

perfluorocarbon compounds (PFCs), and 

three pharmaceuticals (erythromycin, 

nitroglycerin, and quinoline). This list 

also consists of an array of other 

chemicals, ranging from those used for 

industrial manufacturing processes, as 

plasticizers, or in the production of 

pharmaceutical and personal care 

products (PPCPs). 

EPA is interested in receiving 

information and/or comment that may 

inform the exclusion or inclusion of 

chemicals on the second EDSP list. The 

Agency does not plan to respond 

formally to information or comments 

that may be submitted on this 

document, but will add such 

information to the notice docket as 

public record. EPA will consider such 

information and/or comment before 

finalizing the second EDSP list and 

publishing the Schedule for Issuance of 

Orders along with the second EDSP list. 

In addition, please note that by relying 

on the CCL 3 as part of this effort, the 

Agency does not intend to re-open CCL 

3 for public comment or any of the 

individual lists used to create the 

second list of EDSP chemicals and does 

not intend to respond to any such 

comments so submitted. 

mstockstill on DSKH9S0YB1PROD with NOTICES

70252 Federal Register / Vol. 75, No. 221 / Wednesday, November 17, 2010 / Notices 

TABLE 1—SECOND EDSP LIST OF CHEMICALS FOR TIER 1 SCREENING

Chemical name CAS number SDWA PAI RR schedule 

1,1,1,2-Tetrachloroethane .......................................................................................... 630–20–6 X ................ ........................

1,1,1-Trichloroethane ................................................................................................. 71–55–6 X ................ ........................

1,1,2-Trichloroethane ................................................................................................. 79–00–5 X ................ ........................

1,1-Dichloroethane ..................................................................................................... 75–34–3 X ................ ........................

1,1-Dichloroethylene .................................................................................................. 75–35–4 X ................ ........................

1,2,3-Trichloropropane ............................................................................................... 96–18–4 X ................ ........................

1,2,4-Trichlorobenzene .............................................................................................. 120–82–1 X ................ ........................

1,2-Dibromo-3-chloropropane (DBCP) ...................................................................... 96–12–8 X ................ ........................

1,2-Dichloroethane ..................................................................................................... 107–06–2 X ................ ........................

1,2-Dichloropropane .................................................................................................. 78–87–5 X ................ ........................

1,3-Dinitrobenzene ..................................................................................................... 99–65–0 X ................ ........................

1,4-Dioxane ................................................................................................................ 123–91–1 X ................ ........................

1-Butanol .................................................................................................................... 71–36–3 X ................ ........................

2,4,5-TP (Silvex) ........................................................................................................ 93–72–1 X ................ ........................

2-Methoxyethanol ...................................................................................................... 109–86–4 X ................ ........................

2-Propen-1-ol ............................................................................................................. 107–18–6 X ................ ........................

4,4′-Methylenedianiline .............................................................................................. 101–77–9 X ................ ........................

Acetaldehyde ............................................................................................................. 75–07–0 X ................ ........................

Acetamide .................................................................................................................. 60–35–5 X ................ ........................

Acetochlor .................................................................................................................. 34256–82–1 X X ........................

Acetochlor ethanesulfonic acid (ESA) ....................................................................... 187022–11–3 X ................ ........................

Acetochlor oxanilic acid (OA) .................................................................................... 194992–44–4 X ................ ........................

Acrolein ...................................................................................................................... 107–02–8 X X ........................

Acrylamide ................................................................................................................. 79–06–1 X ................ ........................

Alachlor ...................................................................................................................... 15972–60–8 X X ........................

Alachlor ethanesulfonic acid (ESA) ........................................................................... 142363–53–9 X ................ ........................

Alachlor oxanilic acid (OA) ........................................................................................ 171262–17–2 X ................ ........................

alpha-Hexachlorocyclohexane ................................................................................... 319–84–6 X ................ ........................

Aniline ........................................................................................................................ 62–53–3 X ................ ........................

Bensulide ................................................................................................................... 741–58–2 X X FY 2008 

Benzene ..................................................................................................................... 71–43–2 X ................ ........................

Benzo(a)pyrene (PAHs) ............................................................................................. 50–32–8 X ................ ........................

Benzyl chloride .......................................................................................................... 100–44–7 X ................ ........................

Butylated hydroxyanisole ........................................................................................... 25013–16–5 X ................ ........................

Carbon tetrachloride .................................................................................................. 56–23–5 X ................ ........................

Chlordane .................................................................................................................. 57–74–9 X ................ ........................

Chlorobenzene ........................................................................................................... 108–90–7 X ................ ........................

cis-1,2-Dichloroethylene ............................................................................................ 156–59–2 X ................ ........................

Clethodim ................................................................................................................... 99129–21–2 X X FY 2008 

Clofentezine ............................................................................................................... 74115–24–5 ................ X FY 2007 

Clomazone ................................................................................................................. 81777–89–1 ................ X FY 2007 

Coumaphos ................................................................................................................ 56–72–4 ................ X FY 2008 

Cumene hydroperoxide ............................................................................................. 80–15–9 X ................ ........................

Cyanamide ................................................................................................................. 420–04–2 ................ X FY 2008 

Cyromazine ................................................................................................................ 66215–27–8 ................ X FY 2007 

Dalapon ...................................................................................................................... 75–99–0 X ................ ........................

Denatonium saccharide ............................................................................................. 90823–38–4 ................ X FY 2008 

Di(2-ethylhexyl) adipate ............................................................................................. 103–23–1 X ................ ........................

Dichloromethane ........................................................................................................ 75–09–2 X ................ ........................

Dicrotophos ................................................................................................................ 141–66–2 X X FY 2008 

Dimethipin .................................................................................................................. 55290–64–7 X X ........................

Dinoseb ...................................................................................................................... 88–85–7 X ................ ........................

Diuron ........................................................................................................................ 330–54–1 X X ........................

Endothall .................................................................................................................... 145–73–3 X X ........................

Endrin ......................................................................................................................... 72–20–8 X ................ ........................

Epichlorohydrin .......................................................................................................... 106–89–8 X ................ ........................

Erythromycin .............................................................................................................. 114–07–8 X ................ ........................

Ethylbenzene ............................................................................................................. 100–41–4 X ................ ........................

Ethylene dibromide .................................................................................................... 106–93–4 X ................ ........................

Ethylene glycol ........................................................................................................... 107–21–1 X ................ ........................

Ethylene thiourea ....................................................................................................... 96–45–7 X ................ ........................

Ethylurethane ............................................................................................................. 51–79–6 X ................ ........................

Etofenprox .................................................................................................................. 80844–07–1 ................ X FY 2007 

Fenamiphos ............................................................................................................... 22224–92–6 X X FY 2008 

Fenarimol ................................................................................................................... 60168–88–9 ................ X FY 2007 

Fenoxaprop-P-ethyl ................................................................................................... 71283–80–2 ................ X FY 2007 

Fenoxycarb ................................................................................................................ 72490–01–8 ................ X FY 2007 

Flumetsulam .............................................................................................................. 98967–40–9 ................ X FY 2008 

Fomesafen sodium .................................................................................................... 108731–70–0 ................ X FY 2007 

Fosetyl-Al (Aliette) ..................................................................................................... 39148–24–8 ................ X FY 2008 

Glufosinate ammonium .............................................................................................. 77182–82–2 ................ X FY 2008 

HCFC-22 .................................................................................................................... 75–45–6 X ................ ........................

mstockstill on DSKH9S0YB1PROD with NOTICES

Federal Register / Vol. 75, No. 221 / Wednesday, November 17, 2010 / Notices 70253 

TABLE 1—SECOND EDSP LIST OF CHEMICALS FOR TIER 1 SCREENING—Continued 

Chemical name CAS number SDWA PAI RR schedule 

Heptachlor .................................................................................................................. 76–44–8 X ................ ........................

Heptachlor epoxide .................................................................................................... 1024–57–3 X ................ ........................

Hexachlorobenzene ................................................................................................... 118–74–1 X ................ ........................

Hexachlorocyclopentadiene ....................................................................................... 77–47–4 X ................ ........................

Hexane ....................................................................................................................... 110–54–3 X ................ ........................

Hexythiazox ............................................................................................................... 78587–05–0 ................ X FY 2007 

Hydrazine ................................................................................................................... 302–01–2 X ................ ........................

Isoxaben .................................................................................................................... 82558–50–7 ................ X FY 2008 

Lactofen ..................................................................................................................... 77501–63–4 ................ X FY 2007 

Lindane ...................................................................................................................... 58–89–9 X ................ ........................

Methanol .................................................................................................................... 67–56–1 X ................ ........................

Methoxychlor .............................................................................................................. 72–43–5 X ................ ........................

Methyl tert-butyl ether ................................................................................................ 1634–04–4 X ................ ........................

Metolachlor ethanesulfonic acid (ESA) ..................................................................... 171118–09–5 X ................ ........................

Metolachlor oxanilic acid (OA) ................................................................................... 152019–73–3 X ................ ........................

Molinate ..................................................................................................................... 2212–67–1 X ................ ........................

Nitrobenzene .............................................................................................................. 98–95–3 X ................ ........................

Nitroglycerin ............................................................................................................... 55–63–0 X ................ ........................

N-Methyl-2-pyrrolidone .............................................................................................. 872–50–4 X ................ ........................

N-Nitrosodimethylamine (NDMA) .............................................................................. 62–75–9 X ................ ........................

n-Propylbenzene ........................................................................................................ 103–65–1 X ................ ........................

o-Dichlorobenzene ..................................................................................................... 95–50–1 X ................ ........................

o-Toluidine ................................................................................................................. 95–53–4 X ................ ........................

Oxirane, methyl- ........................................................................................................ 75–56–9 X ................ ........................

Oxydemeton-methyl ................................................................................................... 301–12–2 X X FY 2008 

Oxyfluorfen ................................................................................................................. 42874–03–3 X X ........................

Paclobutrazol ............................................................................................................. 76738–62–0 ................ X FY 2007 

p-Dichlorobenzene ..................................................................................................... 106–46–7 X X ........................

Pentachlorophenol ..................................................................................................... 87–86–5 X X ........................

Perchlorate ................................................................................................................. 14797–73–0 X ................ ........................

Perfluorooctane sulfonic acid (PFOS) ....................................................................... 1763–23–1 X ................ ........................

Perfluorooctanoic acid (PFOA) .................................................................................. 335–67–1 X ................ ........................

Picloram ..................................................................................................................... 1918–02–1 X X ........................

Polychlorinated biphenyls .......................................................................................... 1336–36–3 X ................ ........................

Profenofos .................................................................................................................. 41198–08–7 X X FY 2008 

Propetamphos ............................................................................................................ 31218–83–4 ................ X FY 2008 

Propionic acid ............................................................................................................ 79–09–4 ................ X FY 2008 

Pyridate ...................................................................................................................... 55512–33–9 ................ X FY 2007 

Quinclorac .................................................................................................................. 84087–01–4 ................ X FY 2008 

Quinoline .................................................................................................................... 91–22–5 X ................ ........................

Quizalofop-P-ethyl ..................................................................................................... 100646–51–3 ................ X FY 2008 

RDX ........................................................................................................................... 121–82–4 X ................ ........................

sec-Butylbenzene ...................................................................................................... 135–98–8 X ................ ........................

Sodium tetrathiocarbonate ......................................................................................... 7345–69–9 ................ X FY 2008 

Styrene ....................................................................................................................... 100–42–5 X ................ ........................

Sulfosate .................................................................................................................... 81591–81–3 ................ X FY 2007 

Temephos .................................................................................................................. 3383–96–8 ................ X FY 2008 

Terbufos ..................................................................................................................... 13071–79–9 X X FY 2008 

Terbufos sulfone ........................................................................................................ 56070–16–7 X ................ ........................

Tetrachloroethylene ................................................................................................... 127–18–4 X ................ ........................

Thiophanate-methyl ................................................................................................... 23564–05–8 X X ........................

Toluene diisocyanate ................................................................................................. 26471–62–5 X ................ ........................

Toxaphene ................................................................................................................. 8001–35–2 X ................ ........................

trans-1,2-Dichloroethylene ......................................................................................... 156–60–5 X ................ ........................

Trichloroethylene ....................................................................................................... 79–01–6 X ................ ........................

Triethylamine ............................................................................................................. 121–44–8 X ................ ........................

Triflumizole ................................................................................................................. 68694–11–1 ................ X FY 2007 

Trinexapac-ethyl ........................................................................................................ 95266–40–3 ................ X FY 2008 

Triphenyltin hydroxide (TPTH) ................................................................................... 76–87–9 X X ........................

Vinclozolin .................................................................................................................. 50471–44–8 X X ........................

Xylenes (total) ............................................................................................................ 1330–20–7 X X ........................

Ziram .......................................................................................................................... 137–30–4 X X ........................

CAS Number = Chemical Abstract Services Registry Number. 

SDWA = Drinking water chemical based on CCL 3 List or chemicals with National Primary Drinking Water Regulations. 

PAI = Pesticide active ingredient (Current pesticide registration exists). 

RR = OPP Registration Review date. 

mstockstill on DSKH9S0YB1PROD with NOTICES

70254 Federal Register / Vol. 75, No. 221 / Wednesday, November 17, 2010 / Notices 

V. References 

The following is a list of the 

documents that are specifically 

referenced in this document. These 

references are available in the docket 

number identified under General 

Information (Section I.B). 

1. U.S. Congress. House Report 111–180. 

Available at: http://frwebgate.access.gpo.gov/ 

cgi-bin/getdoc.cgi?dbname=111congreports

&docid=f:hr180.111.pdf. 

2. USEPA. 2009. National Primary 

Drinking Water Regulations. May 2009. EPA 

816–F–09–004. Available at: http:// 

www.epa.gov/safewater/consumer/pdf/ 

mcl.pdf. 

3. USEPA. 2009. Drinking Water 

Contaminant Candidate List 3—Final Notice. 

Federal Register. Vol, 74. No 194. p. 51850. 

October 8, 2009. 

4. Initial Compilation of Chemicals and 

Substances Considered for the Second 

Endocrine Disruptor Screening Program List. 

List of Subjects 

Environmental protection, Chemicals, 

Drinking water, Endocrine disruptors, 

Pesticides. 

Dated: September 28, 2010. 

Steve A. Owens, 

Assistant Administrator, Office of Chemical 

Safety and Pollution Prevention. 

[FR Doc. 2010–28818 Filed 11–16–10; 8:45 am] 

BILLING CODE 6560–50–P 

ENVIRONMENTAL PROTECTION 

AGENCY 

[EPA–HQ–OPP–2010–0275; FRL–8853–6] 

Typographical Error in Summary 

Notice of Filing in Docket for 

Polymerized Fatty Acid Esters With 

Aminoalcohol Alkoxylates; Correction 

AGENCY: Environmental Protection 

Agency (EPA). 

ACTION: Notice; correction. 

SUMMARY: EPA issued a notice in the 

Federal Register of June 8, 2010 (75 FR 

32463) (FRL–8827–5), concerning the 

Notice of Filing (NOF) for Pesticide 

Petition (PP) 0E7699 for polymerized 

fatty acid esters with aminoalcohol 

alkoxylates submitted by Exponent, on 

behalf of Croda. Although the NOF that 

appeared in the Federal Register was 

correct, there was a typographical error 

in the summary NOF that was placed in 

docket ID number: EPA–HQ–OPP– 

2010–0275. This document is being 

issued to announce that the Agency has 

placed a corrected summary NOF in the 

docket. Please see docket ID number 

EPA–HQ–OPP–2010–0275 for the 

corrected version. 

FOR FURTHER INFORMATION CONTACT: 

Deirdre Sunderland, Registration 

Division (7505P), Office of Pesticide 

Programs, Environmental Protection 

Agency, 1200 Pennsylvania Ave., NW., 

Washington, DC 20460–0001; telephone 

number: (703) 603–0851; e-mail address: 

sunderland.deirdre@epa.gov. 

SUPPLEMENTARY INFORMATION: 

I. General Information 

A. Does this action apply to me? 

The Agency included in the notice a 

list of those who may be potentially 

affected by this action. If you have 

questions regarding the applicability of 

this action to a particular entity, consult 

the person listed under FOR FURTHER

INFORMATION CONTACT. 

B. How can I get copies of this document 

and other related information? 

EPA has established a docket for this 

action under docket identification (ID) 

number EPA–HQ–OPP–2010–0275. 

Publicly available docket materials are 

available either in the electronic docket 

at http://www.regulations.gov, or, if only 

available in hard copy, at the Office of 

Pesticide Programs (OPP) Regulatory 

Public Docket in Rm. S–4400, One 

Potomac Yard (South Bldg.), 2777 S. 

Crystal Dr., Arlington, VA. The hours of 

operation of this Docket Facility are 

from 8:30 a.m. to 4 p.m., Monday 

through Friday, excluding legal 

holidays. The Docket Facility telephone 

number is (703) 305–5805. 

II. What Does This Correction Do? 

The Notice of Filing (NOF) for 

Pesticide Petition (PP) 0E7699 for 

polymerized fatty acid esters with 

aminoalcohol alkoxylates submitted by 

Exponent, on behalf of Croda, published 

in the Federal Register (FR Doc. 2010– 

13689) of June 8, 2010 (75 FR 32463) 

(FRL–8827–5) is corrected as follows: 

Although the NOF that appeared in the 

Federal Register was correct, there was 

a typographical error in the summary 

NOF that was placed in docket ID 

number: EPA–HQ–OPP–2010–0275. The 

summary referenced an incorrect CAS 

No. 1173188–71–2 as the test chemical 

for the studies provided in support of 

the petition, but should have read CAS 

No. 1173188–81–2. This document is 

being issued to announce that the 

Agency has placed the corrected 

summary NOF in the docket. Please see 

docket ID number EPA–HQ–OPP–2010– 

0275 for the corrected version. 

List of Subjects 

Environmental protection, 

Agricultural commodities, Feed 

additives, Food additives, Pesticides 

and pests, Reporting and recordkeeping 

requirements. 

Dated: November 4, 2010. 

Lois Rossi, 

Director, Registration Division, Office of 

Pesticide Programs. 

[FR Doc. 2010–28804 Filed 11–16–10; 8:45 am] 

BILLING CODE 6560–50–P 

ENVIRONMENTAL PROTECTION 

AGENCY 

[EPA–HQ–OAR–2010–0841; FRL–9228–2] 

PSD and Title V Permitting Guidance 

for Greenhouse Gases 

AGENCY: Environmental Protection 

Agency (EPA). 

ACTION: Notice of availability and public 

comment period. 

SUMMARY: Notice is hereby given that 

the EPA has posted its guidance titled, 

‘‘PSD and Title V Permitting Guidance 

for Greenhouse Gases’’ on its significant 

guidance Internet Web site. EPA invites 

public comments on this guidance 

document during the comment period 

specified below. 

DATES: Comments should be submitted 

on or before December 1, 2010. Please 

refer to SUPPLEMENTARY INFORMATION for 

additional information on the comment 

period. 

ADDRESSES: Submit your comments, 

identified by Docket ID No. EPA–HQ– 

OAR–2010–0841, by one of the 

following methods: 

• http://www.regulations.gov. Follow 

the on-line instructions for submitting 

comments. 

• E-mail: a-and-r-docket@epa.gov. 

Attention Docket ID No. EPA–HQ– 

OAR–2010–0841. 

• Fax: 202–566–9744. Attention 

Docket ID No. EPA–HQ–OAR–2010– 

0841. 

• Mail: Air Docket, Attention Docket 

ID No. EPA–HQ–OAR–2010–0841, 

Environmental Protection Agency, Mail 

Code: 6102T, 1200 Pennsylvania Ave., 

NW., Washington, DC 20460. 

• Hand Delivery: EPA Docket Center, 

1301 Constitution Avenue, NW., Room 

3334, Washington, DC. Such deliveries 

are only accepted during the Docket 

Center’s normal hours of operation, and 

special arrangements should be made 

for deliveries of boxed information. 

Instructions: Direct your comments to 

Docket ID No. EPA–HQ–OAR–2010– 

0841. The EPA’s policy is that all 

comments received will be included in 

the public docket without change and 

may be made available online at http:// 

www.regulations.gov, including any 

personal information provided, unless 

the comment includes information 

claimed to be Confidential Business 

mstockstill on DSKH9S0YB1PROD with NOTICES